Headache

AUSTIN, Texas — Long-term use of eptinezumab resulted in improvements in symptoms and headache days in patients with chronic migraine and medication-overuse headache, according to a poster presented here.

AUSTIN, Texas — Sustained freedom from pain and the most bothersome migraine symptom was achieved in more patients treated with investigational STS 101 compared with placebo, according to a study presented here.

AUSTIN, Texas — Significant improvement was reported in children who have follow-up visits to a headache clinic, although Black patients and patients on Medicaid were less likely to complete these visits, according to data presented here.

AUSTIN, Texas — Hispanic patients with headache disorders were overall satisfied with telemedicine services, regardless of English language proficiency, according to a poster presented here.

I want to reflect on a recent patient I admitted: a woman in her 40s who presented with an intractable headache.

BOSTON — Headache-related quality of life lagged clinical improvement in headaches for individuals with long COVID at 12 to 19 months, according to a poster from the American Academy of Neurology annual meeting.

BOSTON — Fewer patients who took ubrogepant during the premonitory phase went on to have headache when compared with placebo, Peter Goadsby, MD, PhD, FRS, said in this Healio video at the American Academy of Neurology annual meeting.

Vistagen announced that the U.S. Patent and Trademark Office granted a patent for the company’s investigational pherine PH80 nasal spray for the treatment of migraine.

A California-based biopharmaceutical company has announced the completion of its acquisition of Pherin Pharmaceuticals Inc., a drug development firm that specializes in neuropsychiatric and neuroendocrine issues.

U.S. adults who reported a history of migraine or severe headache were 25% more likely to develop hypertension compared with those with no migraine history, with a higher risk for women vs. men, researchers reported.